PVLA Stock-Based Compensation

Palvella Therapeutics Inc · Stock-Based Compensation

PVLA logo

PVLA Stock-Based Compensation

Latest reported$11.46M
PVLA TTM Stock-Based Comp ($287.00K → $11.46M)
High-resolution chart · PNG

PVLA stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Palvella Therapeutics Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
11,457,000
7,735,000
5,453,000
4,585,000
3,012,000
1,725,000
631,000
363,000
287,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.